Get started
Author

Ignacio Puche Sanz

Observed names: I Puche-Sanz, I. Puche Sanz, I. Puche-Sanz, I. Puche‐Sanz, I., Puche-Sanz, Ignacio PUCHE-SANZ, Ignacio Puche, Ignacio Puche – SanzI, Ignacio Puche-Sanz, Ignacio Puche‐Sanz, Puche Sanz, Ignacio
Observed institutions: Jikei University School of Medicine, University College Hospital, Medical University of Silesia, Universidad de Granada, Rigshospitalet, University Medical Center Utrecht, Instituto de Investigación Biosanitaria de Granada, Hospital Universitario Virgen de las Nieves, Complejo Hospitalario Universitario de Granada, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research
ORCID: 0000-0003-4121-0162
Observed ORCID: 0000-0003-4121-0162
OpenAlex ID: A5045332186
Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior
2022 · Alba Rodriguez-Martinez, Iris Simon-Saez, et al. · Theranostics · 74
Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis
2022 · Giorgio Ivan Russo, Timo Soeterik, et al. · Prostate Cancer and Prostatic Diseases · 46
The role of miRNAs as biomarkers in prostate cancer
2019 · J.M. Cozar, I. Robles-Fernandez, et al. · Mutation Research/Reviews in Mutation Research · 44
Primary treatment of painful varicocoele through percutaneous retrograde embolization with fibred coils
2014 · I. Puche‐Sanz, J. F. Flores‐Martín, et al. · Andrology · 43
PDF
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study
2022 · Sinan Khadhouri, Kevin M. Gallagher, et al. · European Urology Focus · 33
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
2022 · Isabel Heidegger, Claudia Kesch, et al. · Therapeutic Advances in Medical Oncology · 32
Cross-Resistance to Abiraterone and Enzalutamide in Castration Resistance Prostate Cancer Cellular Models Is Mediated by AR Transcriptional Reactivation
2021 · Iris Simon, Sonia Perales, et al. · Cancers · 32
Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries
2023 · Steven MacLennan, Nuno Azevedo, et al. · European Urology · 22
Genetic variants of antioxidant enzymes and environmental exposures as molecular biomarkers associated with the risk and aggressiveness of bladder cancer
2022 · D. Martin-Way, I. Puche-Sanz, et al. · The Science of The Total Environment · 20
GSTM1 gene expression and copy number variation in prostate cancer patients—Effect of chemical exposures and physical activity
2018 · Antonio Gómez-Martín, Luis J. Martinez-Gonzalez, et al. · Urologic Oncology Seminars and Original Investigations · 20
Primary Renal Lymphoma: Long-Term Results of Two Patients Treated with a Chemotherapy + Rituximab Protocol
2012 · F. Vázquez-Alonso, I. Puche-Sanz, et al. · Case Reports in Oncological Medicine · 20
PDF
Results at 1 Year from SATURN, A European, Prospective, Multicenter Registry for Male Stress Urinary Incontinence Surgery
2024 · John Heesakkers, Frank Martens, et al. · European Urology Focus · 19
Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness
2017 · Inmaculada Robles-Fernandez, Luis Javier Martinez-Gonzalez, et al. · PLoS ONE · 19
PDF
A Novel, Quick, and Reliable Smartphone-Based Method for Serum PSA Quantification: Original Design of a Portable Microfluidic Immunosensor-Based System
2022 · Francisco Gabriel Ortega, Germán E. Gómez, et al. · Cancers · 17
PDF
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer—Current State and Future Perspectives
2021 · Alexander Kretschmer, Roderick C. N. van den Bergh, et al. · Cancers · 16
A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs
2017 · Ignacio Puche-Sanz, María J. Alvarez-Cubero, et al. · Oncotarget · 15
Follow-up on patients with initial negative mpMRI target and systematic biopsy for PI-RADS ≥ 3 lesions – an EAU-YAU study enhancing prostate cancer detection
2024 · Fabio Zattoni, Giorgio Gandaglia, et al. · Prostate Cancer and Prostatic Diseases · 14
External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension
2023 · J. G. Heetman, E. J. R. J. van der Hoeven, et al. · Prostate Cancer and Prostatic Diseases · 13
PDF
Validación psicométrica de la versión en castellano del cuestionario USS-PROM para pacientes sometidos a cirugía de uretra anterior
2016 · I. Puche-Sanz, D. Martín-Way, et al. · Actas Urológicas Españolas · 13
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study
2023 · Giancarlo Marra, Pawel Rajwa, et al. · Clinical Genitourinary Cancer · 12
PDF
Biopsia líquida y cáncer de próstata. Evidencia actual aplicada a la clínica
2019 · I. Puche-Sanz, A. Rodríguez-Martínez, et al. · Actas Urológicas Españolas · 12
Right Renal Vein Extension With Cryopreserved External Iliac Artery Allografts in Living-donor Kidney Transplantations
2013 · Ignacio Puche-Sanz, Manrique Pascual-Geler, et al. · Urology · 12
Liquid biopsy and prostate cancer. Current evidence applied to clinical practice
2020 · I. Puche-Sanz, A. Rodríguez-Martínez, et al. · Actas Urológicas Españolas (English Edition) · 11
Psychometric validation of the Spanish version of the USS-PROM questionnaire for patients who undergo anterior urethral surgery
2016 · I. Puche-Sanz, D. Martín-Way, et al. · Actas Urológicas Españolas (English Edition) · 11
Metastasis of Renal Cell Carcinoma to the Buccal Mucosa 19 Years after Radical Nephrectomy
2012 · Hernani Gil-Julio, Fernando Vázquez-Alonso, et al. · Case Reports in Oncological Medicine · 11
PDF
Works count: 86
Citation count: 728
H-index: 15
I10-index: 26
Year
Topic
Type